J.W. Cole Advisors’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$993K Buy
2,546
+87
+4% +$36.8K 0.02% 755
2026
Q1
$1.16M Sell
2,459
-42
-2% -$21.1K 0.04% 348
2025
Q4
$1.1M Buy
2,501
+5
+0.2% +$2.32K 0.03% 606
2025
Q3
$1.06M Sell
2,496
-29
-1% -$11.2K 0.02% 695
2025
Q2
$967K Sell
2,525
-1,025
-29% -$369K 0.02% 680
2025
Q1
$1.23M Buy
3,550
+2,103
+145% +$676K 0.04% 478
2024
Q4
$434K Buy
1,447
+402
+38% +$140K 0.02% 654
2024
Q3
$425K Buy
1,045
+71
+7% +$26K 0.02% 656
2024
Q2
$313K Buy
974
+23
+2% +$7.47K 0.01% 691
2024
Q1
$317K Buy
+951
New +$291K 0.02% 670
2023
Q3
Sell
-693
Closed -$210K 761
2023
Q2
$210K Buy
+693
New +$193K 0.02% 694
2020
Q4
Sell
-2,315
Closed -$289K 732
2020
Q3
$289K Buy
+2,315
New +$287K 0.02% 559

Other funds holding HCA

J.W. Cole Advisors's HCA Position: Q2 2026 in Review

J.W. Cole Advisors increased its HCA Healthcare (HCA) stake by 3.5% in Q2 2026, buying an estimated $36.8K and bringing the position to 2,546 shares worth $993K. The position accounts for 0.02% of the portfolio, ranked #755.

J.W. Cole Advisors first reported a position in HCA in Q3 2020 and has held it in 12 quarters since. The position peaked at $1.23M in Q1 2025. 342 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • J.W. Cole Advisors held 2,546 shares of HCA Healthcare worth $993K as of Q2 2026.
  • J.W. Cole Advisors bought 87 HCA Healthcare shares in Q2 2026, an estimated $36.8K.
  • HCA Healthcare made up 0.02% of J.W. Cole Advisors's portfolio in Q2 2026, its #755 holding.
  • J.W. Cole Advisors first reported a position in HCA Healthcare in Q3 2020 and has held it in 12 quarters since.
  • J.W. Cole Advisors's HCA Healthcare position peaked at $1.23M in Q1 2025.
  • 342 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on J.W. Cole Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.